Randomized controlled trial on the effect of 1 ‐hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)

Conclusion1-hour infusion of vincristine is not protective against VIPN. However, in patients receiving concurrent azoles, 1-hour infusion may be less toxic. The difference in treatment outcome is most likely the result of differences in risk profile.

Source: Cancer Medicine - September 21, 2023 Category: Cancer & Oncology Authors: Aniek Uittenboogaard, Marleen H. Berg, Floor C. H. Abbink, Jos W. R. Twisk, Inge M. Sluis, Cor Bos, Marry M. Heuvel ‐Eibrink, Heidi Segers, Christophe Chantrain, Jutte Werff ten Bosch, Leen Willems, Gertjan J. L. Kaspers, Mirjam Esther Vel Tags: RESEARCH ARTICLE Source Type: research